Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13362-26-0

Post Buying Request

13362-26-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13362-26-0 Usage

Description

Ethyl 2-aminopyridine-3-carboxylate is a pyrimidine derivative characterized by its diuretic activity. It is a yellow solid with chemical properties that make it a valuable compound in the pharmaceutical industry.

Uses

Used in Pharmaceutical Industry:
Ethyl 2-aminopyridine-3-carboxylate is used as a diuretic agent for its ability to increase urine output and help regulate the body's fluid balance. This application is particularly useful in treating conditions such as high blood pressure, heart failure, and kidney disorders.
Used in Research and Development:
As a pyrimidine derivative, Ethyl 2-aminopyridine-3-carboxylate is also utilized in research and development for the synthesis of various pharmaceutical compounds and the study of their potential therapeutic effects.
Used in Drug Delivery Systems:
Ethyl 2-aminopyridine-3-carboxylate can be employed in the development of drug delivery systems, where its chemical properties may contribute to the design of novel formulations that enhance the bioavailability and efficacy of other therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 13362-26-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,6 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13362-26:
(7*1)+(6*3)+(5*3)+(4*6)+(3*2)+(2*2)+(1*6)=80
80 % 10 = 0
So 13362-26-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O2/c1-2-12-8(11)6-4-3-5-10-7(6)9/h3-5H,2H2,1H3,(H2,9,10)

13362-26-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H64957)  Ethyl 2-aminonicotinate, 98%   

  • 13362-26-0

  • 5g

  • 360.0CNY

  • Detail
  • Alfa Aesar

  • (H64957)  Ethyl 2-aminonicotinate, 98%   

  • 13362-26-0

  • 25g

  • 1420.0CNY

  • Detail
  • Alfa Aesar

  • (H64957)  Ethyl 2-aminonicotinate, 98%   

  • 13362-26-0

  • 100g

  • 4733.0CNY

  • Detail

13362-26-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 2-Aminonicotinate

1.2 Other means of identification

Product number -
Other names 2-Aminonicotinic Acid Ethyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13362-26-0 SDS

13362-26-0Relevant articles and documents

Fused Pyridine Derivatives from the Wittig Reaction of some Fluorinated Amides

Latham, Elliot J.,Murphy, Steven M.,Stanforth, Stephen P.

, p. 10385 - 10388 (1995)

Compound 2 reacted with phosphorane 3 (R = Et) giving the quinoline derivative 5 whereas thiophenes 7 and 9 gave enamines 8 and 10 respectively with the appropriate phosphorane 3 (R = Me or Et).Pyridine derivative 11 yielded only ethyl 2-aminonicotinate with phosphorane 3 (R = Et).Compounds 8 and 10 gave the fused pyridine derivatives 14 and 15 respectively.

SYNTHESIS, X-RAY STRUCTURE ANALYSIS, AND VIBRATIONAL SPECTRAL STUDIES OF 1-(3-((6-BROMOPYRIDO[2,3-d]PYRIMIDIN-4-YL) OXY)PHENYL)-3-CYCLOPENTYLUREA

Huang, Z.-Y.,Liu, C.-J.,Luo, R.-S.,Mao, S.-N.,Zhou, Z.-X.

, p. 37 - 51 (2022/03/09)

Abstract: A new pyrido[2,3-d]pyrimidine derivative 1-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)-3-cyclopentylurea is designed and synthesized. The final structure is characterized by 1H, 13C, and 2D NMR, MS, FTIR. In addition, the crystal structure of the title compound is determined by X-ray diffraction. With the 6-311G(2d,p) basis set, the molecule is further explored using density functional theory (DFT) by the B3LYP method. The final results show that the DFT optimized structure of the title molecule is consistent with the crystal structure determined by X-ray diffraction. The Hirshfeld surface analysis and the 2D fingerprint plot are given to support the quantitative analysis of intermolecular interactions and contacts generated by supramolecular accumulation in crystals. The interactions of the title molecule are analyzed by the natural bond orbital analysis. Finally, the molecular electrostatic potential and frontier molecular orbitals are further investigated using DFT. [Figure not available: see fulltext.]

Access to pyridines via cascade nucleophilic addition reaction of 1,2,3-triazines with activated ketones or acetonitriles

Zhang, Yuan,Luo, Han,Lu, Qixing,An, Qiaoyu,Li, You,Li, Shanshan,Tang, Zongyuan,Li, Baosheng

supporting information, p. 393 - 396 (2020/05/18)

We studied the cascade nucleophilic addition reactions of 1,2,3-triazines with activated acetonitriles or ketones, which were used to construct highly substituted pyridines that are not easily accessed by conventional methods. The strategy addressed some structural diversity issues currently facing medicinal chemistry, and the resulting pyridines could be used as convenient precursors for the synthesis of related pharmaceuticals. In particular, our method was applied to the syntheses of the marketed drug etoricoxib and several biologically important molecules in a few steps.

Synthesis and antitumor activity of novel pyridino[2,3-d]pyrimidine urea derivatives

Chen, Dongmei,Chen, Yumei,Yang, Di,Zheng, Zhaopeng,Zhou, Zhixu

, p. 1628 - 1636 (2021/05/19)

A series of novel N-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)pyrrolidine-1-carboxamide and 1-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)-3-propylurea derivatives were synthesized. Their antitumor activities against human breast carcinoma cells (MCF-7) and human colon cancer cells (HCT-116) in vitro were evaluated, using sorafenib as a positive control drug. Anticancer bioassays indicated that several compounds exhibited appreciable anticancer activity against MCF-7 and HCT-116 cells. Particularly, compounds 9g and 8b demonstrated the most significant inhibitory effect against HCT-116 and MCF-7 cells, with inhibition ratios of 25.56% and 26.46%, respectively. Additionally, the synthesized pyridine[2,3-d]pyrimidine derivatives containing a urea group moieties exhibited antitumor activities against MCF-7 and HCT-116 cells in vitro.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13362-26-0